Serial Number | 79164322 |
Word Mark | 3RND |
Filing Date | Saturday, March 14, 2015 |
Status | 707 - PARTIAL SECTION 71 ACCEPTED |
Status Date | Thursday, May 25, 2023 |
Registration Number | 4943582 |
Registration Date | Tuesday, April 26, 2016 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, February 9, 2016 |
Goods and Services | [ Database management software; software for application and database integration; software for creating searchable databases; computer application software for mobile phones, cellular phones, handheld computers, smart telephones, PC tablets, personal digital assistants, mobile computers, computers, namely, software used for analysis, storage, data retrieval and visualization of compounds and the cellular effect of compounds in drug discovery; bioinformatics software used to assess the cellular effect of compounds in the drug discovery and development process; computer graphics software; software for accessing information directories that may be downloaded from a global computer network; software for data storage automation; data search software, namely, software for creating searchable database of data; digital image processing software; software for data and document capture, transmission, storage and indexing; scanning software ] |
Pseudo Mark | THREE ROUND |
Goods and Services | [ Scientific research and development; ] scientific and technological services, namely, novel multi-parametric phenotypic screening in the nature of analytical testing [ services and protein isolation ] for the characterization and simultaneous identification of multiple biological and physiological effects caused by drug candidates on live human cell models in the field of pharmaceutical research, drug discovery and characterization of compound effect [, and scientific research and development relating thereto ] ; Scientific and technological services for scientific analysis, testing and research in the fields of pharmaceutical research, drug discovery and characterization of compound effect [, and protein separation, isolation and characterization ] ; [ scientific research services; ] scientific testing and analysis in the fields of pharmaceutical research, drug discovery and characterization of compound effect [, and protein separation, isolation and characterization ] ; computer-assisted scientific research, testing and analysis services in the fields of pharmaceutical research, drug discovery and characterization of compound effect by using mathematical and statistical algorithms to compare and predict the effect of a target compound to that of an approved drug or known toxin, where a biological fingerprint is created and analyzed by measuring the broad physiological and biological effect of said compounds on live human cells; [ laboratory research and analysis services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, and protein separation, isolation and characterization; pharmaceutical research and development; ] Scientific research and scientific and technological services, namely, analytical testing and phenotypic screening services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds [, and protein separation, isolation and characterization; scientific laboratory services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, and protein separation, isolation and characterization; scientific and technological services, namely, analytical testing and phenotypic screening services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, and protein separation, isolation and characterization; provision of information about medical and scientific research in the field of pharmaceuticals; preparation of reports on scientific research; provision of scientific information on technological research in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds; ] provision of scientific information about industrial analysis and research services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds; [ provision of information and data relating to medical research and development and veterinary medical research; consultancy services in the field of pharmaceutical research; consultancy relating to research and development in the field of therapeutics; engineering and ] scientific consultancy services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds [, and protein separation, isolation and characterization; provision of technical advice in the field of scientific and industrial research; consultancy in the field of scientific and industrial research ] |
International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
US Class Codes | 021, 023, 026, 036, 038 |
Class Status Code | G - NOT AVAILABLE |
Class Status Date | Thursday, May 25, 2023 |
Primary Code | 009 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Saturday, May 2, 2015 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | AsedaSciences AG |
Party Type | 30 - Original Registrant |
Legal Entity Type | 99 - Other |
Address | Schindellegi CH-8834 CH |
Party Name | AsedaSciences AG |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | CH |
Party Name | AsedaSciences AG |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | CH |
Event Date | Event Description |
Sunday, March 17, 2024 | PARTIAL INVALIDATION PROCESSED BY THE IB |
Saturday, February 3, 2024 | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
Friday, February 2, 2024 | INVALIDATION PROCESSED |
Thursday, January 25, 2024 | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED |
Thursday, May 25, 2023 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED |
Thursday, May 25, 2023 | REGISTERED - PARTIAL SEC 71 ACCEPTED |
Tuesday, May 16, 2023 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
Tuesday, October 25, 2022 | TEAS SECTION 71 RECEIVED |
Monday, April 26, 2021 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
Friday, August 12, 2016 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Wednesday, July 27, 2016 | FINAL DISPOSITION NOTICE SENT TO IB |
Wednesday, July 27, 2016 | FINAL DISPOSITION PROCESSED |
Tuesday, July 26, 2016 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Tuesday, April 26, 2016 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, February 9, 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, February 9, 2016 | PUBLISHED FOR OPPOSITION |
Friday, February 5, 2016 | NOTIFICATION PROCESSED BY IB |
Wednesday, January 20, 2016 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, January 20, 2016 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Wednesday, January 20, 2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Monday, January 4, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, December 17, 2015 | EXAMINER'S AMENDMENT ENTERED |
Thursday, December 17, 2015 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Thursday, December 17, 2015 | EXAMINERS AMENDMENT E-MAILED |
Thursday, December 17, 2015 | EXAMINERS AMENDMENT -WRITTEN |
Thursday, October 29, 2015 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Thursday, October 29, 2015 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Saturday, July 11, 2015 | REFUSAL PROCESSED BY IB |
Monday, June 22, 2015 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Monday, June 22, 2015 | REFUSAL PROCESSED BY MPU |
Friday, June 19, 2015 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Thursday, June 18, 2015 | NON-FINAL ACTION WRITTEN |
Thursday, June 18, 2015 | ASSIGNED TO EXAMINER |
Wednesday, May 6, 2015 | APPLICATION FILING RECEIPT MAILED |
Saturday, May 2, 2015 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, April 30, 2015 | SN ASSIGNED FOR SECT 66A APPL FROM IB |